Drugmaker will donate meds for US push to end HIV epidemic

WASHINGTON — The Health and Human Services Department announced Thursday that California-Based Gilead Sciences Inc. has agreed to donate medications that reduce the risk of HIV transmission for up to 200,000 people a year.

"Will help us achieve our goal of ending the HIV epidemic in America!" President Donald Trump said in a celebratory tweet.

The pledge may last up to 11 years, said HHS Secretary Alex Azar. Gilead will donate its Truvada prevention pill until a second-generation version becomes available.

The Trump administration has set a goal of ending the HIV epidemic in the U.S. within 10 years.

Carl Schmid of the AIDS Institute called the donation "a really significant step," saying it will make the drug available to uninsured people. It lists for more than $20,000 per patient, per year.

Gilead Sciences said in a news release that the medication donation is one of the largest ever made in the United States and is part of the company's ongoing initiatives to help ensure that everyone who can benefit from the medicine is able to access it.

HIV is the virus that causes AIDS.

You may also interested in

US stocks take small losses as energy companies slide

Aug 19, 2016

US stocks take small losses as the dollar regains a bit of strength and energy companies trade lower

Republicans to query firms that ran Clinton's private server

Aug 23, 2016

Republicans are stepping up attacks on former Secretary of State Hillary Clinton's use of private email, alleging that foreign donors to the Democratic presidential nominee's family charity got preferential treatment from her department

AP NewsBreak: Feds want to ban swimming with Hawaii dolphins

Aug 24, 2016

Federal regulators are proposing a ban on swimming with dolphins in Hawaii

People also read these

Gap offers muted outlook for annual earnings, lower profit

Aug 18, 2016

Gap offers a downbeat annual profit outlook after reporting a 43 percent drop in net income for the second quarter

Valeant, attempting to normalize operations, names new CFO

Aug 22, 2016

Valeant Pharmaceuticals is replacing Robert Rosiello as chief financial officer as the embattled pharmaceutical company attempts to normalize operations amid a host of ongoing investigations and class action suits

McDonald's recalls millions of Happy Meals fitness bands

Aug 23, 2016

McDonald's recalling millions of fitness bands included in Happy Meals because they might cause skin irritation

Emporium Post fulfils the need to know all things about consumers and how businesses can take this opportunity to reach their own customers.

Contact us: sales@emporiumpost.com

Join our mailing list now!